Sort
40,608 grants matching “prostate cancer”
Drug Development for Prostate Cancer and other Metastatic Processes
$602,934William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
PSMA-PET to Guide Prostatectomy: Can PSMA-PET Appropriately Modify Surgery, Reduce Nerve Damage and Optimize Quality-of-Life?
$602,901Clinton David Bahler · Indiana University Indianapolis · R01 · FY2025 · CA
NEXT-GENERATION MOUSE MODELS FOR STUDYING PROSTATE CANCER INITIATION AND PROGRESSION
$602,875The Trustees Of Columbia University In The City Of New York · · FY2009 · Department of the Army
RENEW Research-out to Enhance Wellness Older Survivors
$602,827Duke University · R01 · FY2004 · CA
EXPLOITING RNA EPITRANSCRIPTOMES FOR THE TREATMENT OF LETHAL NEUROENDOCRINE PROSTATE CANCER
$602,814The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2020 · Defense Health Agency
SELECTIVE ACTIVATION OF A PERFORIN-GRANZYME B FUSION PROTEIN TOXIN BY PSA AS THERAPY FOR METASTATIC PROSTATE CANCER
$602,737The Johns Hopkins University · · FY2015 · Department of the Army
Growth Factors and Prostate Cancer Risk
$602,666Meir J Stampfer · Brigham And Women'S Hospital · R01 · FY2006 · CA
MID ATLANTIC PROSTATE CANCER BANK
$602,592George Washington University · U01 · FY2002 · CA
Enhancing Epigenetic Analysis Of Rare Cells With Multi-Phase Microfluidics
$602,554David J Beebe · University Of Wisconsin-Madison · R01 · FY2024 · CA
PET IMAGING HEPARANASE ACTIVITY IN METASTATIC PROSTATE CANCER IN TUMOR XENOGRAFTS
$602,548The Leland Stanford Junior University · · FY2014 · Department of Defense
Accurate MR-based PET Attenuation Correction for Quantitative Clinical Trials
$602,540Raymond F Muzic · Case Western Reserve University · R01 · FY2016 · CA
Automated Assessment for Robotic Suturing Utilizing Deep Learning Algorithms
$602,513Andrew Hung · Cedars-Sinai Medical Center · R01 · FY2025 · CA
Deep Learning-Based Treatment Planning for PSMA RPT
$602,361Georges El Fakhri · Yale University · R01 · FY2025 · CA
Transcriptome-wide association study to identify susceptibility genes for colorectal cancer
$602,189Xingyi Guo · Vanderbilt University Medical Center · R37 · FY2023 · CA
EVALUATION OF MULTIMODAL IMAGING BIOMARKERS OF PROSTATE CANCER
$602,118Vanderbilt University, The · · FY2012 · Department of the Army
Heparan Sulfate in Prostate Cancer
$601,970Lianchun Wang · University Of Georgia · U01 · FY2018 · CA
Mechanisms of resistance to treatment in aggressive prostate cancers
$601,936Adam Sowalsky · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Molecular alterations driving the development of primary prostate cancers
$601,936Adam Sowalsky · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
IMMUNOLOGICAL TARGETING OF TUMOR-INITIATING PROSTATE CANCER CELLS
$601,919The Johns Hopkins University · · FY2013 · Department of Defense
Northwest Community Clinical Oncology Program
$601,888Tacoma General Hospital · U10 · FY2005 · CA
Incorporating residential histories into assessment of cancer risk in a predominantly low-income and racially diverse population
$601,879Melinda Aldrich · Vanderbilt University Medical Center · R01 · FY2023 · CA
ACTIVATION OF A NOVEL DEATH PATHWAY, TARGETED NECROSIS, BY P53 PEPTIDES TO CIRCUMVENT APOPTOTIC RESISTANCE IN PROSTATE CANCER
$601,801The Trustees Of Columbia University In The City Of New York · · FY2009 · Department of the Army
A blood test to identify prostate cancer patients at risk for visceral metastasis
$601,752Edwin Melencio Posadas · Cedars-Sinai Medical Center · R01 · FY2021 · CA
A blood test to identify prostate cancer patients at risk for visceral metastasis
$601,750Edwin Melencio Posadas · Cedars-Sinai Medical Center · R01 · FY2018 · CA
A blood test to identify prostate cancer patients at risk for visceral metastasis
$601,750Edwin Melencio Posadas · Cedars-Sinai Medical Center · R01 · FY2020 · CA